Method of monitoring RNase L activity
Abstract:
The present disclosure relates, in general, to a method for generating chimeric DNA derived from RNase L cleavage products in a sample, and detection of such RNase L cleavage products for diagnosis and treatment of inflammation and infection in a subject.
Public/Granted literature
Information query
Patent Agency Ranking
0/0